Bayhelix Group

Bayhelix Group is an elite, invitation-only professional organization of Chinese life sciences leaders headquartered in Shanghai that fosters cross-border business and early-stage funding opportunities. While not a traditional fund, Bayhelix functions as a network through which senior biotech, pharma, and medtech executives, scientists, and investors pool deal flow and selectively back early-stage companies in biotech, pharma/therapeutics, and medical devices. The group’s value proposition is its concentration of senior cross-border life sciences talent and connectivity between US and Chinese ecosystems.

Members participate at Pre-Seed and Seed stages, with check sizes in the $250k to $1M range typically aggregated across multiple member angels rather than as a single institutional check. Geographic focus spans China and the US, with the group’s cross-border identity reflected in deals that often have operations on both sides of the Pacific.

Founders should understand that Bayhelix is fundamentally a relationship network, not an open-application fund, so warm introductions from existing members are essentially required. Approach with a clear cross-border thesis, credible scientific founders, and a syndication plan that leverages member expertise rather than just capital. Limited public information is available on specific group-led investments.